Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1320735
European Journal of Endocrinology, Vol 132, Issue 6, 735-743
Copyright © 1995 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dugrillon, A.
Right arrow Articles by Gärtner, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Dugrillon, A.
Right arrow Articles by Gärtner, R.

{delta}-Iodolactones decrease epidermal growth factor-induced proliferation and inositol-1,4,5-trisphosphate generation in porcine thyroid follicles—a possible mechanism of growth inhibition by iodide

Alex Dugrillon and Roland Gärtner

Dugrillon A, Gärtner R. {delta}Iodolactones decrease epidermal growth factor-induced proliferation and inositol-1,4,5-trisphosphate generation in porcine thyroid follicles–a possible mechanism of growth inhibition by iodide. Eur J Endocrinol 1995;132:735–43. ISSN 0804–4643

{delta}-Iodolactones (6-iodo-8,11,14-eicosatrienoic {delta}-lactone, {delta}-IL), an iodinated derivative of arachidonic acid, has been shown to be synthesized in thyroid tissue and to inhibit thyroid cell proliferation. It is discussed as a potential mediator of the autoregulatory pathway of iodide in cyclic adenosine-3',5'-monophosphate (cAMP)- and thyrotropin (TSH)-independent growth. We therefore further localized the action of iodide and of {delta}-IL in isolated porcine thyroid follicles. Epidermal growth factor (EGF) and 12-O-tetradecanoylphorbol-13-acetate (TPA) dose dependently stimulated thyroid cell proliferation which could be inhibited by staurosporin (0.1–10 nmol/l), Iodide (2.5–40 µmol/l) as well as {delta}-IL (0.5–2 µmol/l) also dose dependently inhibited EGF- and TPA-induced proliferation. As the calcium ionophor A23187 (100 pmol/l) completely abolished the inhibitory effects of iodide and of {delta}-IL, this may indicate a mechanism of {delta}-IL at or proximal to the calcium-dependent activation of protein kinase C. The growth inhibitory effect was restricted to {delta}-iodolactones when {delta}-Il was compared to 6-iodo-8,11,14,17-eicosatetraenoic {delta}-lactone and 5-iodo-7,10,13,16,19-docosapentaenoic {gamma}-lactone, It could not be prevented with propylthiouracil and therefore deiodination and a different iodide action is unlikely. Inositol-1,4,5-trisphosphate (IP3) and cAMP were measured in extracts from isolated porcine thyroid follicles stimulated with EGF 10 ng/ml) or TSH 1.0U/l) revealing comparable kinetics in IP3 generation, while cAMP formation was only stimulated by TSH, {delta}-Iodolactone (2 µmol/l) only decreased EGF-induced IP3 formation, whereas TSH-induced IP3 and cAMP formation was unchanged. The {gamma}-iodolactone which did not inhibit thyroid cell proliferation, also had no effect on IP 3 generation. These results demonstrate an action of iodide and {delta}-IL at the calcium-dependent signal transduction modulating thyroid cell proliferation by EGF but not TSH. {delta}-Iodolactone acts at or proximal to the generation of IP3 induced by EGF, whereas the TSH-dependent signal transduction seems to be unaltered. {delta}-Iodolactone may therefore be speculated as a specific inhibitory mediator of iodide on growth factor-induced thyroid cell proliferation.

Alex Dugrillon, Zentrallabor der Medizinischen Klinik und Poliklinik, University of Heidelberg, Bergheimer Str. 58, D-69115 Heidelberg. Germany




This article has been cited by other articles:


Home page
EndocrinologyHome page
P. J. Simons, F. G. A. Delemarre, and H. A. Drexhage
Antigen-Presenting Dendritic Cells as Regulators of the Growth of Thyrocytes: A Role of Interleukin-1{beta} and Interleukin-6
Endocrinology, July 1, 1998; 139(7): 3148 - 3156.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 European Society of Endocrinology.